When a longtime critic of an institution ascends to lead it, the arguments he carried in from the outside do not disappear — they find new amplification. Three books targeting Dr. Anthony Fauci, all published through a company tied to Health Secretary Robert F. Kennedy Jr., have found growing audiences precisely because Kennedy now governs the health apparatus Fauci once helped define. The arrangement invites reflection on how ideology, commerce, and power converge in moments of political transition — and on who benefits when a narrative shifts from the margins to the machinery of the state.
Kennedy's Anti-Fauci Books Boost Sales Through Publisher Tied to His Circle
The man criticizing Fauci is now in charge of the agencies Fauci shaped
Mark
Why does it matter that all three books came from the same publisher?
Mimi
Because it suggests this isn't just organic market activity. When the Health Secretary, his son, and a senator all publish through a company run by someone in Kennedy's circle, it raises the question of whether the publisher is functioning as a commercial enterprise or as an extension of Kennedy's political operation.
Mark
But people do publish books criticizing public figures all the time. What makes this different?
Mimi
The timing and the concentration. Kennedy is now running HHS. He's not a critic on the sidelines anymore—he's in power. And the books are selling partly because of that power. The publisher benefits from Kennedy's prominence, and Kennedy benefits from having his critique distributed through a seemingly independent commercial channel.
Mark
Is there evidence the publisher coordinated the releases?
Mimi
The source doesn't say they coordinated the timing or messaging. But the fact that all three chose the same publisher, and that the publisher has ties to Kennedy, suggests at minimum a shared ecosystem. Whether that's coordination or just natural alignment among people who already agree is harder to pin down.
Mark
What happens to these books now that Kennedy is in office?
Mimi
They become part of the official record of how Kennedy thinks about health policy. They're not just books anymore—they're intellectual ammunition for whatever changes he wants to make at HHS. The sales boost matters because it signals public appetite for his worldview.
Mark
Does this violate any rules?
Mimi
Not necessarily. Publishing books isn't illegal, and there's no law against a Health Secretary having published critiques of his predecessor. But it does raise questions about conflicts of interest and whether the publishing arrangement blurs the line between commerce and governance in ways that deserve scrutiny.
The Pulse
- Three prominent Fauci critics — Kennedy, his son, and Senator Rand Paul — released books through the same publisher, a company run by a Kennedy insider, raising immediate questions about coordinated messaging.
- Kennedy's confirmation as HHS Secretary transformed his long-running critique of Fauci from outsider grievance into official proximity to power, injecting urgency into the books' reception.
- Sales have climbed in a self-reinforcing loop: Kennedy's rising profile draws attention to the books, and the books in turn deepen the argument that Fauci's pandemic decisions demand reckoning.
- The publisher's financial interest in selling books and the Health Secretary's political interest in reshaping Fauci's legacy have become nearly impossible to separate, raising conflict-of-interest concerns.
- The central unresolved question is whether these books will translate into substantive policy change at HHS, or whether they will stand as artifacts of a broader effort to rewrite pandemic history.
When a longtime critic of an institution ascends to lead it, the arguments he carried in from the outside do not disappear — they find new amplification. Three books targeting Dr. Anthony Fauci, all published through a company tied to Health Secretary Robert F. Kennedy Jr., have found growing audiences precisely because Kennedy now governs the health apparatus Fauci once helped define. The arrangement invites reflection on how ideology, commerce, and power converge in moments of political transition — and on who benefits when a narrative shifts from the margins to the machinery of the state.
Three books attacking Dr. Anthony Fauci arrived in bookstores with a striking alignment: Health Secretary Robert F. Kennedy Jr., his son, and Senator Rand Paul all published through the same company — one run by a longtime Kennedy associate. The convergence raises questions about whether the arrangement reflects genuine market demand, coordinated messaging, or both.
Kennedy has centered his public identity on criticism of Fauci for years, particularly around pandemic response and vaccine policy. His 2026 appointment to lead the Department of Health and Human Services elevated that critique from political outsider territory into the heart of federal governance. The books, each approaching Fauci's record from a different angle, have found an audience energized by Kennedy's new position.
The publisher's ties to Kennedy's inner circle are not concealed, but they are consequential. A company with direct connections to the Health Secretary has become the primary vehicle for the most prominent published critiques of a figure Kennedy has long opposed — placing commercial publishing, political advocacy, and governance in uncomfortable proximity.
Kennedy now oversees the very institutions Fauci shaped across decades at the National Institute of Allergy and Infectious Diseases. The books function simultaneously as historical argument and political ammunition, their sales climbing in a feedback loop driven by the Secretary's own prominence. Whether they will influence actual health policy — or be remembered simply as a symptom of a broader effort to rewrite the pandemic's history — remains the question the arrangement has not yet answered.
Three books attacking Dr. Anthony Fauci arrived in bookstores with a curious alignment: all three authors—Health Secretary Robert F. Kennedy Jr., his son, and Senator Rand Paul—published through the same company, one run by a longtime Kennedy associate. The convergence raises questions about whether the publishing arrangement reflects genuine market demand, coordinated messaging, or both.
Kennedy has made criticism of Fauci central to his public identity for years, particularly around pandemic response decisions and vaccine policy. His appointment as head of the Department of Health and Human Services in 2026 elevated that critique from the margins of political discourse into the machinery of federal health governance. The books—each offering a distinct angle on Fauci's record—have found an audience energized by Kennedy's new position and the attention it has drawn to his longstanding grievances.
The publisher's connection to Kennedy's inner circle is not hidden, but it is worth noting. A company led by someone with direct ties to the Health Secretary is now the primary vehicle for distributing the most prominent published critiques of a figure Kennedy has spent years opposing. This arrangement sits at the intersection of politics, publishing, and influence—a space where commercial success and ideological alignment can be difficult to disentangle.
Sales have reportedly climbed as Kennedy's profile has risen. The increased visibility of the Health Secretary has turned attention toward the books themselves, creating a feedback loop: Kennedy's prominence drives interest in the critiques, which in turn amplifies the narrative that Fauci's decisions warrant serious reconsideration. Whether readers are drawn by genuine intellectual curiosity about pandemic policy or by the partisan energy surrounding Kennedy's appointment remains an open question.
The arrangement also illustrates a broader dynamic in contemporary American politics: the blurring of lines between publishing, advocacy, and governance. Kennedy now oversees the very health institutions and policies that Fauci shaped during his decades at the National Institute of Allergy and Infectious Diseases. The books serve as both historical argument and political ammunition. They exist in a space where commercial publishing meets ideological warfare, where a publisher's financial interest in selling books aligns neatly with a Health Secretary's interest in reshaping the narrative around his predecessor's legacy.
What remains to be seen is whether the books will influence actual health policy—whether Kennedy's control of HHS will lead to substantive changes in how the department operates, or whether the publishing arrangement will be remembered as a symptom of a broader effort to rewrite the history of the pandemic and the role Fauci played in it. For now, the books are selling, the narrative is shifting, and the man who spent years criticizing Fauci from the outside is now in a position to act on those criticisms from within.
Notable Quotes
Kennedy has made criticism of Fauci central to his public identity for years, particularly around pandemic response decisions and vaccine policy— reporting from the arrangement
Want the full story?
Read the original at The New York Times ↗
Business